leading brands of glp-1 agonists in biopharma Market Report 2025-2033, By Product, Molecule, and Geo 20 Companies in Glucagon-Like Peptide-1
Description
10.3132/dvdr.2006.024 74 GrimshawC
Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: a 52-week, open-label, phase IV study
But there was a clear consensus among experts at the ASAM conference: more research is needed
Should Patients Wait for Retatrutide
Mild to severe side effects can occur, and you should report them to your doctor and healthcare team
Ozempic, also called semaglutide, may be the most well-known, but five other GLP-1s in an injectable form are used to treat diabetes
